间充质干细胞英文全称
Introduction
One of the most promising areas of regenerative medicine is the use of mesenchymal stem cells, also known as mesenchymal stromal cells (MSCs), for tissue repair. These cells have the ability to differentiate into various cell types, secrete trophic factors that promote tissue growth and repair, and modulate the immune response. Among the mesenchymal stem cells, the most widely used in clinical trials and therapies are the bone marrow-derived mesenchymal stem cells. However, another type of MSCs has gained attention due to its abundance, accessibility, and potential therapeutic applications, the adipose-derived mesenchymal stem cells, which are also known as adipose-derived stem cells (ADSCs) or adipose-derived stromal cells (ASCs).
What are ADSCs?
Adipose-derived mesenchymal stem cells are a type of multipotent progenitor cells that reside in the adipose tissue or fat. These cells were first discovered in 2001 by Zuk and colleagues, who isolated and characterized them from liposuction aspirates. Adipose tissue is an abundant source of pluripotent cells, which can be easily harvested through a minimally invasive procedure with little discomfort to the patient.
How are ADSCs obtained?
The process of obtaining ADSCs involves harvesting adipose tissue from the patients body through liposuction. Before the procedure, the areas from where the adipose tissue will be removed are treated with a local anesthetic. Then the surgeon or physician makes small incisions and inserts a small blunt cannula that is connected to a suction device. This method allows for the removal of fat without damaging the tissue or the cells. After the adipose tissue is harvested, it is processed to isolate the ADSCs, which are cultured and expanded in the laboratory.
How do ADSCs work?
ADSCs have the potential to differentiate into various cell types, including adipocytes, chondrocytes, osteoblasts, and myocytes. However, their most significant therapeutic potential comes from their paracrine effects, which involve the secretion of various bioactive molecules, such as growth factors, cytokines, and extracellular vesicles. These molecules can stimulate tissue repair and regeneration by promoting cell proliferation, angiogenesis, and immunomodulation. Additionally, they can inhibit apoptosis, inflammation, and fibrosis, which are common pathological processes in many diseases.
What are the therapeutic applications of ADSCs?
ADSCs have been investigated for their therapeutic potential in numerous preclinical and clinical studies. Some of the diseases and conditions that ADSCs have shown promise in treating or alleviating symptoms include:
- Wound healing: ADSCs can accelerate wound closure and promote tissue regeneration in various types of wounds, including chronic ulcers, burns, and surgical incisions.
- Orthopedic disorders: ADSCs can differentiate into bone, cartilage, and muscle cells, making them useful in treating conditions such as osteoarthritis and muscular dystrophy.
- Neurological disorders: ADSCs can migrate to the site of brain or spinal cord injury and promote the regeneration of damaged tissues by secreting growth factors and suppressing inflammation and apoptosis.
- Cardiovascular disorders: ADSCs can improve cardiac function by enhancing angiogenesis, reducing fibrosis, and promoting the survival and differentiation of cardiomyocytes.
- Autoimmune disorders: ADSCs can suppress the immune response by modulating the activity of T cells, B cells, and natural killer cells, making them a potential therapy for diseases such as multiple sclerosis and rheumatoid arthritis.
Conclusion
Adipose-derived mesenchymal stem cells are a promising source of regenerative cells for various therapeutic applications. Their abundance, accessibility, and safety make them an attractive alternative to the bone marrow-derived mesenchymal stem cells. The paracrine effects of ADSCs provide a significant advantage, allowing for their use in a wider range of diseases and conditions. However, further research is needed to optimize their isolation, expansion, and delivery to patients. As more studies are conducted, it is likely that ADSCs will become a mainstream therapy for tissue regeneration and repair.
相关文章
发表评论